Skip to main content

Advertisement

Table 1 The global death and incidence of all cancers and 29 specified cancer groups in 1990 and 2017

From: Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study

Tumor types 1990 2017
Death Incidence Death Incidence
Number 103(95% UI) Age-standardized per 100,000 (95% UI) Number 103(95% UI) Age-standardized per 100,000 (95% UI) Number 103(95% UI) Age-standardized per 100,000 (95% UI) Number 103(95% UI) Age-standardized per 100,000 (95% UI)
Total-Neoplasms 5753 (5903–5661) 142.5 (145.89–140.47) 12,144 (14146–10595) 296.09 (349.12–255.32) 9556 (9692–9396) 121.21 (122.92–119.12) 24,362 (27310–21911) 306.75 (343.47–275.8)
Esophageal cancer 311 (323–301) 7.72 (8.01–7.48) 310 (322–301) 7.57 (7.85–7.33) 436 (448–425) 5.48 (5.63–5.34) 473 (485–459) 5.9 (6.06–5.74)
Stomach cancer 769 (795–752) 19.32 (19.96–18.91) 864 (890–847) 21.32 (21.95–20.9) 865 (885–848) 10.98 (11.23–10.77) 1221 (1255–1189) 15.36 (15.78–14.97)
Liver cancer 453 (490–426) 10.8 (11.68–10.18) 472 (512–445) 11.05 (11.97–10.42) 819 (856–790) 10.21 (10.65–9.85) 953 (997–917) 11.8 (12.34–11.35)
Larynx cancer 94 (97–91) 2.27 (2.34–2.2) 133 (136–129) 3.14 (3.22–3.06) 126 (130–123) 1.57 (1.61–1.53) 211 (216–206) 2.59 (2.65–2.54)
Tracheal, bronchus, and lung cancer 1033 (1063–1015) 25.54 (26.25–25.1) 1079 (1110–1060) 26.34 (27.05–25.89) 1883 (1923–1844) 23.74 (24.24–23.25) 2163 (2213–2117) 27.13 (27.75–26.55)
Breast cancer 350 (381–333) 8.66 (9.37–8.28) 879 (936–846) 20.91 (22.16–20.19) 612 (641–589) 7.65 (8.01–7.37) 1961 (2023–1891) 24.19 (24.96–23.34)
Cervical cancer 189 (210–173) 4.45 (4.96–4.1) 416 (466–383) 9.1 (10.17–8.4) 260 (269–241) 3.21 (3.32–2.98) 601 (625–554) 7.38 (7.67–6.81)
Uterine cancer 59 (61–56) 1.48 (1.54–1.43) 184 (189–178) 4.41 (4.53–4.28) 85 (87–83) 1.07 (1.1–1.05) 407 (418–397) 5 (5.14–4.88)
Prostate cancer 208 (235–165) 5.95 (6.66–4.68) 478 (533–359) 12.67 (14.06–9.49) 416 (490–357) 5.5 (6.46–4.71) 1334 (1698–1171) 16.94 (21.53–14.84)
Colon and rectum cancer 503 (526–488) 13.31 (13.87–12.96) 826 (855–807) 21.2 (21.87–20.75) 896 (916–876) 11.52 (11.77–11.27) 1833 (1873–1792) 23.22 (23.73–22.7)
Lip and oral cavity cancer 97 (102–94) 2.38 (2.47–2.29) 186 (192–180) 4.41 (4.55–4.28) 194 (202–185) 2.42 (2.52–2.31) 390 (404–374) 4.84 (5.02–4.65)
Nasopharynx cancer 52 (54–49) 1.19 (1.25–1.13) 87 (93–81) 1.88 (2–1.76) 70 (72–67) 0.86 (0.89–0.82) 110 (116–104) 1.35 (1.42–1.28)
Other pharynx cancer 56 (61–49) 1.32 (1.43–1.16) 78 (83–70) 1.8 (1.93–1.63) 117 (124–102) 1.45 (1.53–1.26) 179 (189–160) 2.19 (2.3–1.96)
Gallbladder and biliary tract cancer 106 (119–101) 2.79 (3.14–2.68) 120 (133–115) 3.13 (3.46–3.02) 174 (185–154) 2.23 (2.38–1.99) 211 (225–186) 2.71 (2.89–2.39)
Pancreatic cancer 196 (200–193) 5.1 (5.18–5.02) 195 (199–192) 5.01 (5.1–4.94) 441 (449–433) 5.62 (5.72–5.52) 448 (456–439) 5.69 (5.8–5.57)
Malignant skin melanoma 34 (43–28) 0.85 (1.07–0.71) 118 (147–93) 2.74 (3.42–2.17) 62 (70–48) 0.78 (0.89–0.61) 309 (366–238) 3.87 (4.58–2.97)
Non-melanoma skin cancer 30 (32–29) 0.83 (0.86–0.79) 3751 (5756–2235) 95.39 (149.21–55.03) 65 (66–63) 0.85 (0.87–0.82) 7664 (10570–5251) 97.11 (134.21–66.66)
Ovarian cancer 96 (101–92) 2.37 (2.49–2.28) 152 (162–145) 3.54 (3.76–3.4) 176 (181–171) 2.2 (2.26–2.14) 286 (295–278) 3.54 (3.66–3.44)
Testicular cancer 7 (7–6) 0.14 (0.15–0.13) 40 (41–38) 0.75 (0.78–0.72) 8 (8–7) 0.1 (0.1–0.09) 71 (74–69) 0.9 (0.94–0.87)
Kidney cancer 68 (71–63) 1.69 (1.75–1.56) 207 (220–189) 4.72 (4.95–4.29) 139 (143–129) 1.77 (1.82–1.64) 393 (405–371) 4.94 (5.08–4.66)
Bladder cancer 115 (118–108) 3.15 (3.24–2.99) 249 (256–237) 6.42 (6.58–6.13) 197 (206–192) 2.57 (2.69–2.51) 474 (492–462) 6.04 (6.27–5.9)
Brain and nervous system cancer 142 (171–117) 3.04 (3.58–2.56) 194 (234–159) 3.97 (4.71–3.33) 247 (265–213) 3.12 (3.34–2.68) 405 (443–351) 5.17 (5.64–4.46)
Thyroid cancer 22 (24–21) 0.55 (0.6–0.52) 95 (101–90) 2.11 (2.24–2.01) 41 (44–40) 0.52 (0.56–0.51) 255 (272–246) 3.15 (3.36–3.03)
Mesothelioma 17 (21–14) 0.44 (0.52–0.37) 21 (25–18) 0.52 (0.62–0.43) 30 (31–29) 0.38 (0.39–0.37) 35 (36–34) 0.44 (0.45–0.42)
Hodgkin lymphoma 36 (39–27) 0.75 (0.83–0.58) 73 (79–56) 1.43 (1.56–1.1) 33 (38–28) 0.41 (0.48–0.35) 101 (119–88) 1.29 (1.51–1.12)
Non-Hodgkin lymphoma 135 (142–130) 3.19 (3.34–3.1) 207 (217–200) 4.75 (4.93–4.62) 249 (253–243) 3.18 (3.24–3.11) 488 (497–479) 6.18 (6.29–6.06)
Multiple myeloma 52 (61–48) 1.35 1.59–1.26) 65 (77–60) 1.65 (1.93–1.52) 107 (119–99) 1.37 (1.51–1.25) 153 (173–141) 1.92 (2.17–1.76)
Leukemia 265 (293–234) 5.81 (6.32–5.27) 354 (399–308) 7.42 (8.17–6.62) 348 (365–317) 4.5 (4.73–4.12) 518 (548–472) 6.76 (7.16–6.15)
Other malignant neoplasms 220 (229–206) 5.07 (5.25–4.79) 308 (325–287) 6.74 (7.02–6.33) 360 (371–331) 4.61 (4.75–4.25) 716 (740–656) 9.16 (9.47–8.4)
  1. UI uncertainty interval